Mild to Moderate  :@0.244625:0.149047:0.808579:0.149047:0.808579:0.088631:0.244625:0.088631:0.049235:0.019190:0.029113:0.041011:0.011404:0.028839:0.043972:0.013597:0.049235:0.044355:0.041395:0.033225:0.037831:0.035419:0.029058:0.032842:0.012117:0.012117
essential hypertension:@0.127952:0.199289:0.849919:0.199289:0.849919:0.138873:0.127952:0.138873:0.033225:0.031142:0.031142:0.033225:0.043478:0.029058:0.019190:0.037392:0.028730:0.011404:0.043423:0.033445:0.033225:0.033225:0.037831:0.029058:0.033225:0.043478:0.031142:0.019190:0.044355:0.042382
 3,5:@0.851711:0.178538:0.901001:0.178538:0.901001:0.143315:0.851711:0.143315:0.007064:0.016526:0.008854:0.016845
Provides effective BP control with mono-or combination therapy :@0.123429:0.259290:0.786499:0.259290:0.786499:0.231240:0.123429:0.231240:0.014996:0.008648:0.012593:0.010738:0.005513:0.012593:0.011940:0.009301:0.005800:0.011940:0.007759:0.007759:0.011940:0.011521:0.008935:0.005513:0.010738:0.011940:0.005800:0.016329:0.015571:0.005800:0.011521:0.012593:0.012932:0.008935:0.008648:0.012593:0.005565:0.005800:0.015780:0.005513:0.008935:0.012958:0.005800:0.019908:0.012593:0.012932:0.012593:0.010790:0.012593:0.008726:0.005800:0.011521:0.012593:0.019908:0.012593:0.005513:0.012932:0.010973:0.008935:0.005513:0.012593:0.012932:0.005800:0.008935:0.012958:0.011940:0.008726:0.010973:0.012593:0.012175:0.005800
1,2:@0.786489:0.249535:0.802908:0.249535:0.802908:0.233182:0.786489:0.233182:0.004965:0.003549:0.007905
• Improves insulin sensitivity in insulin resistant patients, ideal for patients with metabolic syndrome:@0.123429:0.279639:0.789669:0.279639:0.789669:0.260939:0.123429:0.260939:0.006166:0.003867:0.004685:0.013272:0.008395:0.005765:0.008395:0.007158:0.007960:0.006200:0.003867:0.003675:0.008622:0.006200:0.008447:0.003710:0.003675:0.008622:0.003867:0.006200:0.007960:0.008622:0.006200:0.003675:0.005957:0.003675:0.007158:0.003675:0.005957:0.008116:0.003867:0.003675:0.008622:0.003867:0.003675:0.008622:0.006200:0.008447:0.003710:0.003675:0.008622:0.003867:0.005765:0.007960:0.006200:0.003675:0.006200:0.005957:0.007315:0.008622:0.005957:0.003867:0.008395:0.007315:0.005957:0.003675:0.007960:0.008622:0.005957:0.006200:0.004058:0.003867:0.003675:0.008395:0.007960:0.007315:0.003710:0.003867:0.005574:0.008395:0.005817:0.003867:0.008395:0.007315:0.005957:0.003675:0.007960:0.008622:0.005957:0.006200:0.003867:0.010520:0.003675:0.005957:0.008639:0.003867:0.013272:0.007960:0.005957:0.007315:0.008395:0.008395:0.003710:0.003675:0.007681:0.003867:0.006200:0.008116:0.008622:0.008395:0.005765:0.008395:0.013272:0.007960
 4:@0.789657:0.273136:0.797861:0.273136:0.797861:0.262234:0.789657:0.262234:0.002254:0.005950
• Well tolerated with a low potential for drug interactions :@0.123429:0.295600:0.508958:0.295600:0.508958:0.276899:0.123429:0.276899:0.006166:0.003867:0.014822:0.007960:0.003710:0.003710:0.003867:0.005957:0.008395:0.003710:0.007960:0.005817:0.007315:0.005957:0.007960:0.008395:0.003867:0.010520:0.003675:0.005957:0.008639:0.003867:0.007315:0.003867:0.003710:0.008395:0.010520:0.003867:0.008395:0.008395:0.005957:0.007960:0.008622:0.005957:0.003675:0.007315:0.003710:0.003867:0.005574:0.008395:0.005817:0.003867:0.008395:0.005817:0.008447:0.007994:0.003867:0.003675:0.008622:0.005957:0.007960:0.005817:0.007315:0.007681:0.005957:0.003675:0.008395:0.008622:0.006200:0.003867
2:@0.508950:0.289096:0.514220:0.289096:0.514220:0.278194:0.508950:0.278194:0.005270
Dosage and directions for use: :@0.355108:0.349196:0.666396:0.349196:0.666396:0.321145:0.355108:0.321145:0.019229:0.012593:0.009301:0.010973:0.011992:0.011940:0.005800:0.010973:0.012932:0.012593:0.005800:0.012593:0.005513:0.008648:0.011940:0.011521:0.008935:0.005513:0.012593:0.012932:0.009301:0.005800:0.008360:0.012593:0.008726:0.005800:0.012671:0.009301:0.011940:0.006688:0.005800
3:@0.666390:0.339441:0.674493:0.339441:0.674493:0.323087:0.666390:0.323087:0.008103
  :@0.126875:0.398057:0.135897:0.398057:0.135897:0.376240:0.126875:0.376240:0.004511:0.004511
Adults:@0.135896:0.397228:0.180153:0.397228:0.180153:0.378528:0.135896:0.378528:0.011548:0.008395:0.008447:0.003710:0.005957:0.006200
0,2 mg in the morning:@0.349343:0.380496:0.501430:0.380496:0.501430:0.361796:0.349343:0.361796:0.011008:0.004058:0.009040:0.003867:0.013272:0.007994:0.003867:0.003675:0.008622:0.003867:0.005957:0.008639:0.007960:0.003867:0.013272:0.008395:0.005817:0.008622:0.003675:0.008622:0.007994
The dose may be titrated after 3 weeks to 0,4 mg, given as one dose or as divided:@0.349343:0.396457:0.894116:0.396457:0.894116:0.377757:0.349343:0.377757:0.008169:0.008639:0.007960:0.003867:0.008395:0.008395:0.006200:0.007960:0.003867:0.013272:0.007315:0.008116:0.003867:0.008395:0.007960:0.003867:0.005957:0.003675:0.005957:0.005817:0.007315:0.005957:0.007960:0.008395:0.003867:0.007315:0.005574:0.005957:0.007960:0.005817:0.003867:0.009266:0.003867:0.010520:0.007960:0.007960:0.007803:0.006200:0.003867:0.005957:0.008395:0.003867:0.011008:0.003884:0.010206:0.003867:0.013272:0.007890:0.004058:0.003867:0.007994:0.003675:0.007158:0.007960:0.008622:0.003867:0.007315:0.006200:0.003867:0.008395:0.008622:0.007960:0.003867:0.008395:0.008395:0.006200:0.007960:0.003867:0.008395:0.005817:0.003867:0.007315:0.006200:0.003867:0.008395:0.003675:0.007158:0.003675:0.008395:0.007960:0.008395
doses (morning and evening) until a satisfactory response has been achieved.:@0.349343:0.412417:0.862661:0.412417:0.862661:0.393717:0.349343:0.393717:0.008395:0.008395:0.006200:0.007960:0.006200:0.003867:0.005800:0.013272:0.008395:0.005817:0.008622:0.003675:0.008622:0.007994:0.003867:0.007315:0.008622:0.008395:0.003867:0.007960:0.007158:0.007960:0.008622:0.003675:0.008622:0.007629:0.005992:0.003867:0.008447:0.008622:0.005957:0.003675:0.003710:0.003867:0.007315:0.003867:0.006200:0.007315:0.005957:0.003675:0.006200:0.005574:0.007315:0.007681:0.005957:0.008395:0.005939:0.008116:0.003867:0.005765:0.007960:0.006200:0.008395:0.008395:0.008622:0.006200:0.007960:0.003867:0.008639:0.007315:0.006200:0.003867:0.008395:0.007960:0.007960:0.008622:0.003867:0.007315:0.007681:0.008639:0.003675:0.007960:0.007158:0.007960:0.008395:0.003936
* In a subgroup of patients with TG ≥ 2,30 mmol/L + HDL-C ≤ 0,88 mmol/L:@0.119667:0.434402:0.463470:0.434402:0.463470:0.421935:0.119667:0.421935:0.003808:0.002578:0.003123:0.005748:0.002578:0.004877:0.002578:0.004134:0.005632:0.005597:0.005330:0.003843:0.005597:0.005632:0.005597:0.002578:0.005597:0.003716:0.002578:0.005597:0.004877:0.003971:0.002450:0.005306:0.005748:0.003971:0.004134:0.002578:0.007013:0.002450:0.003971:0.005759:0.002578:0.005411:0.008500:0.002578:0.005237:0.002578:0.006026:0.002705:0.006177:0.007338:0.002578:0.008848:0.008848:0.005597:0.002473:0.003716:0.005701:0.002578:0.005817:0.002578:0.008871:0.008674:0.005179:0.004668:0.008209:0.002578:0.005237:0.002578:0.007338:0.002601:0.006653:0.006653:0.002578:0.008848:0.008848:0.005597:0.002473:0.003716:0.005701
Reference: 1. :@0.105601:0.827510:0.156848:0.827510:0.156848:0.816439:0.105601:0.816439:0.006198:0.004267:0.003241:0.004267:0.003180:0.004267:0.005019:0.004074:0.004267:0.002469:0.002245:0.003373:0.002134:0.002245
Waters J, Ashford J, Jäger B, Verboom CN, Wonnacott S. Use of moxonidine as initial therapy and in combination in the treatment of essential hypertension – results of the TOPIC (Trial of Physiotens In :@0.156848:0.827432:0.904887:0.827432:0.904887:0.816524:0.156848:0.816524:0.008372:0.004013:0.003221:0.004389:0.003139:0.003363:0.002002:0.003861:0.002113:0.002002:0.006482:0.003363:0.004785:0.002997:0.004643:0.003139:0.004643:0.002002:0.003861:0.002113:0.002002:0.003861:0.004003:0.004409:0.004389:0.003139:0.002002:0.006005:0.002113:0.002002:0.005710:0.004389:0.003139:0.004643:0.004643:0.004643:0.007488:0.002002:0.006929:0.007498:0.002113:0.002002:0.008382:0.004643:0.004775:0.004775:0.004013:0.004227:0.004643:0.003221:0.003221:0.002002:0.005110:0.002042:0.002002:0.006797:0.003363:0.004389:0.002002:0.004643:0.002997:0.002002:0.007488:0.004613:0.003952:0.004643:0.004775:0.001890:0.004643:0.001890:0.004775:0.004389:0.002002:0.004013:0.003363:0.002002:0.001890:0.004775:0.001890:0.003221:0.001890:0.004013:0.001910:0.002002:0.003221:0.004785:0.004389:0.003139:0.004013:0.004643:0.004481:0.002002:0.004013:0.004775:0.004643:0.002002:0.001890:0.004775:0.002002:0.004227:0.004643:0.007488:0.004643:0.001890:0.004775:0.004013:0.003221:0.001890:0.004643:0.004775:0.002002:0.001890:0.004775:0.002002:0.003221:0.004785:0.004389:0.002002:0.003221:0.003109:0.004389:0.004013:0.003221:0.007488:0.004389:0.004775:0.003221:0.002002:0.004643:0.002997:0.002002:0.004389:0.003363:0.003363:0.004389:0.004775:0.003221:0.001890:0.004013:0.001910:0.002002:0.004785:0.004481:0.004643:0.004389:0.003139:0.003221:0.004389:0.004775:0.003363:0.001890:0.004643:0.004775:0.002002:0.005608:0.002002:0.003109:0.004389:0.003363:0.004674:0.001910:0.003221:0.003363:0.002002:0.004643:0.002997:0.002002:0.003221:0.004785:0.004389:0.002002:0.004481:0.008087:0.005801:0.002611:0.006929:0.002002:0.003241:0.004003:0.003139:0.001890:0.004013:0.001910:0.002002:0.004643:0.002997:0.002002:0.005710:0.004785:0.004481:0.003363:0.001890:0.004643:0.003221:0.004389:0.004775:0.003363:0.002002:0.002479:0.005029:0.002256
Combination) Study. J Clin Basic Cardiol 1999;2(2):219-224.  Fenton C, Keating GM, Lyseng-Williamson KA. Moxonidine: A Review of its Use in Essential Hypertension. Drugs 2006;66(4):477-496. :@0.105601:0.836743:0.858690:0.836743:0.858690:0.825834:0.105601:0.825834:0.006807:0.004643:0.007488:0.004643:0.001890:0.004775:0.004013:0.003221:0.001890:0.004643:0.004674:0.003241:0.002002:0.005009:0.003221:0.004674:0.004643:0.004328:0.002042:0.002002:0.003861:0.002002:0.006858:0.001910:0.001890:0.004775:0.002002:0.005994:0.004013:0.003363:0.001890:0.004227:0.002002:0.006858:0.004013:0.003139:0.004643:0.001890:0.004643:0.001910:0.002002:0.003058:0.005263:0.005263:0.005263:0.002377:0.005019:0.003241:0.005019:0.003241:0.002347:0.005019:0.003058:0.005263:0.003566:0.005019:0.004887:0.005700:0.002042:0.002256:0.009134:0.005192:0.004389:0.004775:0.003221:0.004643:0.004775:0.002002:0.006929:0.002113:0.002002:0.005720:0.004389:0.004013:0.003221:0.001890:0.004775:0.004409:0.002002:0.007183:0.008504:0.002113:0.002002:0.004501:0.004481:0.003363:0.004389:0.004775:0.004409:0.003627:0.008758:0.001890:0.001910:0.001910:0.001890:0.004013:0.007488:0.003363:0.004643:0.004775:0.002002:0.006025:0.006482:0.002042:0.002002:0.008412:0.004613:0.003952:0.004643:0.004775:0.001890:0.004643:0.001890:0.004775:0.004389:0.002347:0.002002:0.006482:0.002002:0.006157:0.004389:0.003922:0.001890:0.004389:0.005883:0.002002:0.004643:0.002997:0.002002:0.001890:0.003221:0.003363:0.002002:0.006797:0.003363:0.004389:0.002002:0.001890:0.004775:0.002002:0.005639:0.003363:0.003363:0.004389:0.004775:0.003221:0.001890:0.004013:0.001910:0.002002:0.007356:0.004481:0.004643:0.004389:0.003139:0.003221:0.004389:0.004775:0.003363:0.001890:0.004643:0.004775:0.002042:0.002002:0.007203:0.003139:0.004674:0.004409:0.003363:0.002002:0.005019:0.006167:0.006167:0.005263:0.002377:0.005263:0.005263:0.003129:0.005629:0.003241:0.002347:0.005669:0.004623:0.004562:0.003891:0.005649:0.005263:0.005263:0.002042:0.002256
2. :@0.335979:0.836820:0.345367:0.836820:0.345367:0.825749:0.335979:0.825749:0.005009:0.002134:0.002245
3.:@0.858182:0.836820:0.865619:0.836820:0.865619:0.825749:0.858182:0.825749:0.005050:0.002388
 Physiotens  :@0.865365:0.836743:0.915128:0.836743:0.915128:0.825834:0.865365:0.825834:0.002256:0.005710:0.004785:0.004481:0.003363:0.001890:0.004643:0.003221:0.004389:0.004775:0.003617:0.004378:-0.684798
®:@0.907974:0.832949:0.912872:0.832949:0.912872:0.826589:0.907974:0.826589:0.004899
Package Insert. Abbott Laboratories (Pty) Ltd, South Africa. 15 April 2011.  Haenni A, Lithell H. Moxonidine improves insulin sensitivity in insuline-resistant hpertensives. J Hypertens 1999;17(3):S29-S35   Cynt:@0.105600:0.846053:0.892014:0.846053:0.892014:0.835144:0.105600:0.835144:0.005527:0.004013:0.004227:0.004257:0.004013:0.004409:0.004389:0.002002:0.002479:0.004775:0.003363:0.004389:0.003139:0.003221:0.002042:0.002002:0.006482:0.004643:0.004643:0.004643:0.003221:0.003221:0.002002:0.004735:0.004013:0.004643:0.004643:0.003139:0.004013:0.003221:0.004643:0.003139:0.001890:0.004389:0.003363:0.002002:0.003241:0.005751:0.003221:0.004328:0.003241:0.002002:0.004633:0.003221:0.004643:0.002113:0.002002:0.005161:0.004643:0.004674:0.003221:0.004785:0.002002:0.006370:0.002997:0.003139:0.001890:0.004227:0.004013:0.002042:0.002002:0.003058:0.005161:0.002002:0.006482:0.004643:0.003139:0.001890:0.001910:0.002002:0.005019:0.006167:0.003058:0.003058:0.002042:0.002256:0.009672:0.007315:0.004013:0.004389:0.004775:0.004775:0.001890:0.002002:0.006482:0.002113:0.002002:0.004735:0.001890:0.003221:0.004785:0.004389:0.001910:0.001910:0.002002:0.007396:0.002042:0.002002:0.008412:0.004613:0.003952:0.004643:0.004775:0.001890:0.004643:0.001890:0.004775:0.004389:0.002002:0.001890:0.007488:0.004643:0.003109:0.004643:0.003922:0.004389:0.003363:0.002002:0.001890:0.004775:0.003363:0.004674:0.001910:0.001890:0.004775:0.002002:0.003363:0.004389:0.004775:0.003363:0.001890:0.003221:0.001890:0.003922:0.001890:0.003221:0.004481:0.002002:0.001890:0.004775:0.002002:0.001890:0.004775:0.003363:0.004674:0.001910:0.001890:0.004775:0.004389:0.003942:0.003109:0.004389:0.003363:0.001890:0.003363:0.003221:0.004013:0.004775:0.003221:0.002002:0.004785:0.004643:0.004389:0.003139:0.003221:0.004389:0.004775:0.003363:0.001890:0.003922:0.004389:0.003363:0.002042:0.002002:0.003861:0.002002:0.007356:0.004481:0.004643:0.004389:0.003139:0.003221:0.004389:0.004775:0.003363:0.002002:0.003058:0.005263:0.005263:0.005263:0.002377:0.003058:0.004562:0.003241:0.005080:0.003241:0.002347:0.005161:0.005019:0.005263:0.003475:0.005161:0.005151:0.005161:0.002256:0.006990:0.002002:0.006533:0.004481:0.004775:0.003475
4. :@0.381728:0.846130:0.391918:0.846130:0.391918:0.835059:0.381728:0.835059:0.005812:0.002134:0.002245
5.:@0.863505:0.846130:0.871003:0.846130:0.871003:0.835059:0.863505:0.835059:0.005110:0.002388
®:@0.891756:0.842259:0.896655:0.842259:0.896655:0.835900:0.891756:0.835900:0.004899
 :@0.896655:0.846053:0.898910:0.846053:0.898910:0.835144:0.896655:0.835144:0.002256
Package Insert. Abbott Laboratories (Pty) Ltd, South Africa. 15 April 2011. S3 PHYSIOTENS 0,2. Each filmcoated tablet contains 0,2 mg moxonidine. Reg. No. 32/7.1.3/0139.  S3 PHYSIOTENS  0,4. Each fi lm-coated :@0.105598:0.855363:0.926719:0.855363:0.926719:0.844455:0.105598:0.844455:0.005527:0.004013:0.004227:0.004257:0.004013:0.004409:0.004389:0.002002:0.002479:0.004775:0.003363:0.004389:0.003139:0.003221:0.002042:0.002002:0.006482:0.004643:0.004643:0.004643:0.003221:0.003221:0.002002:0.004735:0.004013:0.004643:0.004643:0.003139:0.004013:0.003221:0.004643:0.003139:0.001890:0.004389:0.003363:0.002002:0.003241:0.005751:0.003221:0.004328:0.003241:0.002002:0.004633:0.003221:0.004643:0.002113:0.002002:0.005161:0.004643:0.004674:0.003221:0.004785:0.002002:0.006370:0.002997:0.003139:0.001890:0.004227:0.004013:0.002042:0.002002:0.003058:0.005161:0.002002:0.006482:0.004643:0.003139:0.001890:0.001910:0.002002:0.005019:0.006167:0.003058:0.003058:0.002042:0.002002:0.005161:0.005151:0.002002:0.005801:0.007508:0.005486:0.005161:0.002611:0.007965:0.004602:0.005761:0.007610:0.005415:0.005660:0.006167:0.002113:0.005019:0.002042:0.002002:0.005639:0.004013:0.004227:0.004785:0.002002:0.002550:0.002550:0.001910:0.007488:0.004227:0.004643:0.004013:0.003221:0.004389:0.004643:0.002002:0.003221:0.004013:0.004643:0.001910:0.004389:0.003221:0.002002:0.004227:0.004643:0.004775:0.003221:0.004013:0.001890:0.004775:0.003363:0.002002:0.006167:0.002113:0.005019:0.002002:0.007488:0.004409:0.002002:0.007488:0.004613:0.003952:0.004643:0.004775:0.001890:0.004643:0.001890:0.004775:0.004389:0.002042:0.002002:0.006157:0.004389:0.004348:0.002042:0.002002:0.007417:0.004643:0.002042:0.002002:0.005151:0.005019:0.002997:0.004562:0.001788:0.003058:0.002042:0.005151:0.002946:0.006167:0.003058:0.005151:0.005263:0.002042:0.002002:0.002002:0.005161:0.005151:0.002002:0.005801:0.007508:0.005486:0.005161:0.002611:0.007965:0.004602:0.005761:0.007610:0.005415:0.004490:0.002002:0.006167:0.002012:0.005700:0.002042:0.002002:0.005639:0.004013:0.004227:0.004785:0.002002:0.002550:0.002550:0.002002:0.001910:0.007488:0.003942:0.004227:0.004643:0.004013:0.003221:0.004389:0.004897:-0.720773
® :@0.451705:0.851570:0.457771:0.851570:0.457771:0.845210:0.451705:0.845210:0.004751:0.001315
®:@0.833292:0.851570:0.838191:0.851570:0.838191:0.845210:0.833292:0.845210:0.004899
tablet contains 0,4 mg moxonidine. Reg. No. 32/7.1.3/0141.  S3 CYNT  0,2. Each fi lm-coated tablet contains 0,2 mg moxonidine. Reg, No.: 32/7.1.3/0136. S3 CYNT  0,4. Each film-coated tablet contains 0,4 mg :@0.105598:0.864673:0.900722:0.864673:0.900722:0.853765:0.105598:0.853765:0.003221:0.004013:0.004643:0.001910:0.004389:0.003221:0.002002:0.004227:0.004643:0.004775:0.003221:0.004013:0.001890:0.004775:0.003363:0.002002:0.006167:0.002012:0.005700:0.002002:0.007488:0.004409:0.002002:0.007488:0.004613:0.003952:0.004643:0.004775:0.001890:0.004643:0.001890:0.004775:0.004389:0.002042:0.002002:0.006157:0.004389:0.004348:0.002042:0.002002:0.007417:0.004643:0.002042:0.002002:0.005151:0.005019:0.002997:0.004562:0.001788:0.003058:0.002042:0.005151:0.002946:0.006167:0.003058:0.005659:0.003058:0.002042:0.002002:0.002002:0.005161:0.005151:0.002002:0.006929:0.005486:0.007610:0.004856:0.004494:0.002002:0.006167:0.002113:0.005019:0.002042:0.002002:0.005639:0.004013:0.004227:0.004785:0.002002:0.002550:0.002550:0.002002:0.001910:0.007488:0.003942:0.004227:0.004643:0.004013:0.003221:0.004389:0.004643:0.002002:0.003221:0.004013:0.004643:0.001910:0.004389:0.003221:0.002002:0.004227:0.004643:0.004775:0.003221:0.004013:0.001890:0.004775:0.003363:0.002002:0.006167:0.002113:0.005019:0.002002:0.007488:0.004409:0.002002:0.007488:0.004613:0.003952:0.004643:0.004775:0.001890:0.004643:0.001890:0.004775:0.004389:0.002042:0.002002:0.006157:0.004389:0.004348:0.002113:0.002002:0.007417:0.004643:0.002042:0.002347:0.002002:0.005151:0.005019:0.002997:0.004562:0.001788:0.003058:0.002042:0.005151:0.002946:0.006167:0.003058:0.005151:0.005263:0.002042:0.002002:0.005161:0.005151:0.002002:0.006929:0.005486:0.007610:0.004856:0.004490:0.002002:0.006167:0.002012:0.005700:0.002042:0.002002:0.005639:0.004013:0.004227:0.004785:0.002002:0.002550:0.002550:0.001910:0.007488:0.003942:0.004227:0.004643:0.004013:0.003221:0.004389:0.004643:0.002002:0.003221:0.004013:0.004643:0.001910:0.004389:0.003221:0.002002:0.004227:0.004643:0.004775:0.003221:0.004013:0.001890:0.004775:0.003363:0.002002:0.006167:0.002012:0.005700:0.002002:0.007488:0.004663:-0.706968
®:@0.367470:0.860880:0.372369:0.860880:0.372369:0.854520:0.367470:0.854520:0.004899
®:@0.723211:0.860880:0.728110:0.860880:0.728110:0.854520:0.723211:0.854520:0.004899
moxonidine. Reg, No.: 32/7.1.3/0138:@0.105601:0.873984:0.243076:0.873984:0.243076:0.863075:0.105601:0.863075:0.007488:0.004613:0.003952:0.004643:0.004775:0.001890:0.004643:0.001890:0.004775:0.004389:0.002042:0.002002:0.006157:0.004389:0.004348:0.002113:0.002002:0.007417:0.004643:0.002042:0.002347:0.002002:0.005151:0.005019:0.002997:0.004562:0.001788:0.003058:0.002042:0.005151:0.002946:0.006167:0.003058:0.005151:0.005822
For full prescribing information refer to the package insert approved by the Medicines Regulatory Authority. Further information is available on request from the holder of the registration. Abbott Laboratories S.A. (Pty) Ltd. :@0.105601:0.892604:0.926711:0.892604:0.926711:0.881696:0.105601:0.881696:0.005182:0.004643:0.003139:0.002002:0.002997:0.004674:0.001910:0.001910:0.002002:0.004643:0.003109:0.004389:0.003363:0.004227:0.003139:0.001890:0.004643:0.001890:0.004775:0.004409:0.002002:0.001890:0.004775:0.002997:0.004643:0.003139:0.007488:0.004013:0.003221:0.001890:0.004643:0.004775:0.002002:0.003109:0.004389:0.002997:0.004389:0.003139:0.002002:0.003221:0.004643:0.002002:0.003221:0.004785:0.004389:0.002002:0.004643:0.004013:0.004227:0.004257:0.004013:0.004409:0.004389:0.002002:0.001890:0.004775:0.003363:0.004389:0.003139:0.003221:0.002002:0.004013:0.004643:0.004643:0.003109:0.004643:0.003922:0.004389:0.004643:0.002002:0.004643:0.004481:0.002002:0.003221:0.004785:0.004389:0.002002:0.008423:0.004389:0.004643:0.001890:0.004227:0.001890:0.004775:0.004389:0.003363:0.002002:0.006157:0.004389:0.004409:0.004674:0.001910:0.004013:0.003221:0.004643:0.003211:0.004481:0.002002:0.006411:0.004674:0.003221:0.004785:0.004643:0.003139:0.001890:0.003221:0.004328:0.002042:0.002002:0.005212:0.004674:0.003139:0.003221:0.004785:0.004389:0.003139:0.002002:0.001890:0.004775:0.002997:0.004643:0.003139:0.007488:0.004013:0.003221:0.001890:0.004643:0.004775:0.002002:0.001890:0.003363:0.002002:0.004013:0.003922:0.004013:0.001890:0.001910:0.004013:0.004643:0.001910:0.004389:0.002002:0.004643:0.004775:0.002002:0.003109:0.004389:0.004643:0.004674:0.004389:0.003363:0.003221:0.002002:0.002997:0.003109:0.004643:0.007488:0.002002:0.003221:0.004785:0.004389:0.002002:0.004785:0.004643:0.001910:0.004643:0.004389:0.003139:0.002002:0.004643:0.002997:0.002002:0.003221:0.004785:0.004389:0.002002:0.003109:0.004389:0.004409:0.001890:0.003363:0.003221:0.003139:0.004013:0.003221:0.001890:0.004643:0.004775:0.002042:0.002002:0.006482:0.004643:0.004643:0.004643:0.003221:0.003221:0.002002:0.004735:0.004013:0.004643:0.004643:0.003139:0.004013:0.003221:0.004643:0.003139:0.001890:0.004389:0.003363:0.002002:0.005110:0.002042:0.006482:0.002042:0.002002:0.003241:0.005751:0.003221:0.004328:0.003241:0.002002:0.004633:0.003221:0.004643:0.002296:0.002256
Co. Reg. No. 1940/014043/07. Abbott Place, 219 Golf Club Terrace, Constantia Kloof, 1709. Tel: (011) 858 2000. Date of Publication of this promotional material: June 2019. Promo. No. ZAEPHS190124:@0.105601:0.901914:0.871736:0.901914:0.871736:0.891006:0.105601:0.891006:0.006807:0.004643:0.002042:0.002002:0.006157:0.004389:0.004348:0.002042:0.002002:0.007417:0.004643:0.002042:0.002002:0.003058:0.005263:0.005700:0.006167:0.002946:0.006167:0.003058:0.005700:0.006167:0.005700:0.005151:0.002946:0.006086:0.004562:0.002042:0.002002:0.006482:0.004643:0.004643:0.004643:0.003221:0.003221:0.002002:0.005710:0.001910:0.004013:0.004227:0.004389:0.002113:0.002002:0.005019:0.003058:0.005263:0.002002:0.007112:0.004643:0.001910:0.002997:0.002002:0.006858:0.001910:0.004674:0.004643:0.002002:0.003901:0.004389:0.003139:0.003139:0.004013:0.004227:0.004389:0.002113:0.002002:0.006807:0.004643:0.004775:0.003363:0.003221:0.004013:0.004775:0.003221:0.001890:0.004013:0.002002:0.005842:0.001910:0.004643:0.004643:0.002946:0.002113:0.002002:0.003058:0.004511:0.006167:0.005263:0.002042:0.002002:0.003901:0.004389:0.001910:0.002347:0.002002:0.003089:0.006167:0.003058:0.003058:0.003241:0.002002:0.005568:0.005161:0.005568:0.002002:0.005019:0.006167:0.006167:0.006167:0.002042:0.002002:0.007193:0.004013:0.003221:0.004389:0.002002:0.004643:0.002997:0.002002:0.005598:0.004674:0.004643:0.001910:0.001890:0.004227:0.004013:0.003221:0.001890:0.004643:0.004775:0.002002:0.004643:0.002997:0.002002:0.003221:0.004785:0.001890:0.003363:0.002002:0.004643:0.003109:0.004643:0.007488:0.004643:0.003221:0.001890:0.004643:0.004775:0.004013:0.001910:0.002002:0.007488:0.004013:0.003221:0.004389:0.003139:0.001890:0.004013:0.001910:0.002347:0.002002:0.003861:0.004674:0.004775:0.004389:0.002002:0.005019:0.006167:0.003058:0.005263:0.002042:0.002002:0.005578:0.003109:0.004643:0.007488:0.004643:0.002042:0.002002:0.007417:0.004643:0.002042:0.002002:0.005171:0.006482:0.005761:0.005801:0.007508:0.005161:0.003058:0.005263:0.006167:0.003058:0.004887:0.005954